Skip to main content
PLOS One logoLink to PLOS One
. 2023 Sep 7;18(9):e0285020. doi: 10.1371/journal.pone.0285020

A versatile nuclei extraction protocol for single nucleus sequencing in non-model species–Optimization in various Atlantic salmon tissues

Rose Ruiz Daniels 1,*, Richard S Taylor 1, Ross Dobie 2, Sarah Salisbury 1, James J Furniss 1, Emily Clark 1, Daniel J Macqueen 1, Diego Robledo 1
Editor: Sven Winter3
PMCID: PMC10484441  PMID: 37676875

Abstract

The use of single cell sequencing technologies has exploded over recent years, and is now commonly used in many non-model species. Sequencing nuclei instead of whole cells has become increasingly popular, as it does not require the processing of samples immediately after collection. Here we present a highly effective nucleus isolation protocol that outperforms previously available method in challenging samples in a non-model specie. This protocol can be successfully applied to extract nuclei from a variety of tissues and species.

Introduction and background

Single cell RNA sequencing has become a standard tool for profiling transcriptomic diversity across thousands of individual cells, in a wide range of species and tissues [1]. A major limitation of this technology is that it typically requires the isolation and immediate processing of live cells from fresh tissue, which in many circumstances is not practical. As a result, single nucleus RNA sequencing (snRNA-seq), requiring the isolation of nuclei instead of the whole cells, has been widely adopted to allow the use of frozen samples that can be stored for several months prior to processing, while yielding comparable results [2, 3]. The most critical step in a snRNA-seq protocol is the successful isolation of high quality nuclei, with a choice several options available for the dissociation and nuclei isolation [46]. Extensive work has been performed in mammals to develop a toolbox of protocols for nuclei extraction in a variety of tissues [35]. A review of the available protocols, including consideration of their performance in non-model species, concluded that mincing the tissue in salt tween (TST) represents the most effective method for nuclear isolation from frozen tissue in terms of the diversity of cell types captured and reducing background noise [7].

Here we present an improved, more robust protocol for the extraction of high quality nuclei from a variety of tissues in non-model species. This protocol has been adapted from a TST based method previously considered the gold standard, which has been used previously in a snRNA-seq study in Atlantic salmon liver [8], and which now results in superior data quality in a variety of tissues tested in Atlantic salmon. We apply the protocol to flash frozen skin samples from Atlantic salmon, which are challenging tissues to work with due to their toughness, the presence of connective tissue and fat deposits, and hard tissue such as scales. We include notes throughout the protocol to allow the user to optimise for a different tissue types. While the Chromium 10x platform was used to partition nuclei and prepare the snRNA-seq libraries, the nuclei are suitable for other platforms and applications. The aim of this protocol is to capture 7,000 nuclei per single-nuclei RNA sequencing library using the Chromium Single Cell 3’ Reagent Kits v2 or v3 (10x Genomics). Given its utility for isolating nuclei from difficult to dissociate tissue types, we anticipate this protocol will be broadly applicable for snRNA-seq of non-model organisms and unconventional tissue types.

Materials

Sampling and storage for nuclear isolation

Approximately ~45mg (about the size of a grain of rice) of tissue is placed in a clearly labelled cryotube and immediately flash frozen in liquid nitrogen. It is critical that the tissue is preserved as rapidly as possible to minimise RNA degradation and cell stress that may induce transcriptional response. In the absence of liquid nitrogen, samples can be frozen in dry ice [8]. Samples should be stored at -80°C or colder, and should be processed as soon as possible, ideally within 3 months of flash freezing. Longer periods of storage are possible but nuclei and RNA quality will be reduced, impacting the final libraries.

Reagents

Quantities listed here result in sufficient buffer to process two samples.

Notes on use of RNase inhibitor:

  • The choice of RNase inhibitor can negatively affect RNA integrity during nuclear isolation and all steps prior to reverse transcription. The RNase inhibitor used here was recommended by 10x for use with their platforms, providing superior performance to alternatives8. For alternative platforms, consult with the protocol or manufacturer for a compatible product.

  • Add RNase inhibitor to buffers immediately prior to nuclear extraction.

  • RNase inhibitor is only necessary for samples destined for downstream sequencing. For trials that will not be sequenced, the RNase inhibitor can be omitted to save on costs.

  • RNase inhibitor concentration can be increased up to 1000U/ml depending on RNase activity levels in the tissue. Some downstream applications, such as multi-omics ATAC-seq/RNA-seq, require higher levels of RNase inhibitor.

Workflow

Pre-chill the centrifuge to 4°C. Samples should be kept frozen on dry ice or liquid nitrogen until immediately prior to nuclear isolation. All subsequent sample-handling steps should be performed on ice. Make sure all materials are available Table 1 before starting protocol. All buffers should be chilled on ice. Make sure buffers are available Table 2, all concentrations are adjustable to number of samples required. Start by preparing 2x ST (Table 3) as master buffer to prepare the rest. Subsequently make ST (Table 4), TST (Table 5) and PBS+0.02% BSA (Table 6) prior to starting the isolation,

  1. Place a 6-well tissue culture plate on ice and add 1ml of TST to one well. Place the frozen tissue sample into the well containing the TST. If the sample is stuck to the cryotube, remove it using tweezers while ensuring the sample does not defrost, and place immediately into the culture plate with TST.

  2. Keeping the culture plate on ice, mince tissue initially using Tungsten Carbide scissors for 30 seconds (if required) and then with Noyes Spring Scissors (Fine Science Tools, catalog no. 15514–12) for up to 5 minutes until finely minced. Using a P1000 with a low retention filter tip, gently pipette up and down for up to a further 5 minutes. The total time in the dissociation buffer is critical and the duration of the scissor and pipette steps needs optimisation using non-valuable samples. The use of scissors should be the minimum time necessary for no solid lumps of tissue to remain. Pipetting duration is optimised by observing the nuclei under a microscope and adjusting the dissociation time to the minimum needed for full dissociation and lysing of cells (Fig 1). Typical tissue dissociation takes a total of 5–10 minutes. Non-tissue samples such as blood samples require as little as 1 minute of gentle pipetting in the TST and no use of scissors.

  3. Pass lysate through a 40μm strainer into an empty well in the tissue culture plate and wash the cell strainer with 1ml TST. Add 3ml of chilled 1xST buffer to the lysate to stop the reaction. Move the 5ml of lysate to a labelled 15ml falcon tube on ice.

  4. Centrifuge at 4°C for 5 minutes at 500g in a swinging bucket centrifuge. When nuclei yield is low, centrifugation time can be increased to 10 minutes to maximise yield. In samples with high recovery 10 minutes is not recommended as longer centrifugation duration can result in the clumping of nuclei and higher doublet rates in the final data.

  5. Discard the supernatant with a P1000 pipette, and gently resuspend the pellet in PBS-BSA. Resuspension volume depends on the size of the pellet and recommended nucleus concentration levels for the downstream platform. We recommend 1ml for most tissues and 100–500μl for more difficult tissues that yield fewer nuclei. For skin and fin, 400μl is recommended.

  6. Filter the nucleus solution a second time. The size of the filter will depend on the type of tissue, e.g. for tissues such as liver and head kidney a 40μm cell strainer will suffice, whereas for gill a 30μm filter may be better given the higher amount of tough debris, which could negatively impact later stages. For tissues that produce a lot of debris such as fin and skin, 20μm is recommended. If the lysate does not pass through at once, pipette up and down very gently with a wide bore pipette.

  7. A) Count the nuclei using a haemocytometer. In this step, the nuclei may also be examined under a microscope to ascertain the level of debris present and the integrity of the nuclear membranes. High levels of debris may indicate that a finer filter should be used, or using less tissue initially. Incomplete dissociation or evidence of damaged nuclear membranes indicates that the time spent in the TST should be adjusted (Fig 1).

    B) The nuclei may also be counted using a Bio-Rad TC20, or similar platform, to count the proportion of viable cells. Nuclei are identified as “dead”, therefore a good nuclei isolation will have a small percentage of live cells. <4% live cells is ideal, but <12% is acceptable. A high proportions of live cells indicates incomplete nuclear isolation, and more time in the TST solution is needed. We advise against trusting the nucleus count given by automated counters, as they often substantially underestimate the true number of nuclei present. This would result in excessive nuclei being loaded into the Chromium Controller, leading to high doublet rates and low sequencing saturation.

  8. Load the nuclei suspension into a Chromium Chip and into the Chromium Controller, aiming to recover 7,000 nuclei as per 10x recommendations with a concentration of between 700 to 1200 nuclei per μl. In the case of some tissues such as fin, re-adjust the target recovery to 5000 as the concentration of nuclei obtained can be lower.

Table 1. List of materials required for the correct implementation of this protocol, as well as the supplier and catalogue number.

Material Supplier Catalogue number
Noyes Spring Scissors Fine Science Tools 15514–12
Tungsten Carbide Straight 11.5 cm Fine Scissors Fine Science Tools 14558–11
40 μm Falcon™ cell strainer Thermo Fisher Scientific 08-771-2
30 μm Falcon™ cell strainer Corning 352235
20 μm cell strainer for 1.5ml tubes pluriSelect 43-10020-50
LoBind Tubes 1.5 ml Eppendorf 0030108051
6 well Tissue Culture plate Stem Cell Technologies 38016
Falcon tubes 15 ml corning CLS430055
C-chip disposable haemocytometer VWR 82030–468

Table 2. Complete list of reagents and volumes required to make up the buffers for the correct implementation of this protocol.

Reagent Supplier Product code Volume (μl)
NaCl Thermo Fisher Scientific. AM9759 292
Tris-HCl pH 7.5 Thermo Fisher Scientific 15567027 100
CaCl2 VWR E506-100ml 10
MgCl2 Sigma–Aldrich M1028 210
Nuclease-free water VWR E476-500ml 14245
Protector RNase inhibitor Sigma Aldrich PN-3335399001 31
1% Tween-20 Sigma Aldrich. P-7949 120
2% BSA New England Biolabs. B9000S 20
Molecular grade PBS 985

Table 3. Reagents and amounts to prepare 2x salt-Tris (ST) (10 ml).

Reagent Volume (μl) Final concentration (mM)
NaCl 292 146
Tris-HCl pH 7.5 100 10
CaCl2 10 1
MgCl2 210 21
Nuclease-free water 9,388

Notes: Prepare fresh 2xST on the day for each isolation. Chill prior to use.

Table 4. Reagents and amounts to prepare 1x ST with RNase inhibitor (6ml).

Reagent Volume (μl) Final concentration
2xST 2,997
Nuclease-free water 2,997
Protector RNase inhibitor 6 40U/ml

Notes: Add RNase inhibitor immediately prior to use. RNase inhibitor volume can be increased up to 1000U/ml if the target tissue is rich in RNases (e.g. spleen; pancreas).

Table 5. Reagents and amounts to prepare TST with RNase inhibitor (4ml).

Reagent Volume (μl) Final concentration
2xST 2,000
1% Tween-20 120 0.03%
2% BSA 20 0.02%
Nuclease-free water 1,840
Protector RNase inhibitor 20 200U/ml

Notes: Prepare fresh TST on the day of the isolation. Chill prior to use. Prepare the 1% Tween from the 10% Tween stock solution using nuclease free H2O. RNase inhibitor volume can be increased up to 1000U/ml if the target tissue is rich in RNases.

Table 6. Reagents and amounts to prepare PBS+0.02% BSA with RNase inhibitor (1ml).

Reagent Volume (μl) Final concentration
Ultra-pure molecular grade PBS 985
2% BSA 10 0.02%
Protector RNase inhibitor 5 200U/ml

Notes: It is possible that nuclei may stick together in clumps after centrifugation. This can be observed under a microscope (Fig 1A illustrates an example of this). This is undesirable as it may lead to high rates of “doublets”, when more than one nucleus is encapsulated in a single droplet in the microfluidics system, resulting in each transcript being labelled with the same cellular barcode. To prevent this, BSA concentration can be increased up to 2%. This protocol assumes the nuclei will be suspended in a final buffer of 500 μl of PBS+BSA, as recommended for the 10x Chromium system. This final buffer may vary for alternative platforms and tissues adjust volumes accordingly.

Fig 1. Three examples of nuclear dissociation trials in Atlantic salmon liver at x40 magnification, stained with trypan blue.

Fig 1

A. Nuclei did not spend sufficient time in the dissociation buffer resulting in incomplete dissociation. This may result in the obstruction of the microfluidic device and failure of the library. B. Nuclei perfectly dissociated showing minimal aggregation, ideal for library preparation. C. Nuclei have been in the dissociation buffer for too long, resulting in degradation of the nuclear membrane, which will result in suboptimal library quality.

Testing the protocol

Using 45mg flash frozen Atlantic skin samples, we compared a version of the mincing+ST nuclear isolation protocol (V1), to our new protocol (V2), where we optimized several steps to improve performance. The loading buffer was changed from ST to PBS+BSA and RNAse inhibitor, RNA inhibitor was also added to all buffers, the mincing step was adjusted by using a combination of Noyes spring scissors, Carbide scissors and pipetting up and down. Filter size was decreased to remove more debris, and the centrifugation length optimized to enhance nuclei recovery.

After isolation with the two different protocols, nuclei were processed with the 10x Chromium™ Single Cell Platform using the Chromium™ Single Cell 3`Library and Gel Bead Kit v3.1 and Chromium™ Single Cell A Chip Kit (both 10x Genomics) as per the manufacturer’s protocol, with a target recovery of 7000 nuclei per sample. The nuclei were loaded into a channel of a Chromium 3’ Chip and partitioned into droplets using the Chromium controller before the captured RNA for each nucleus was barcoded and reverse transcribed. The resulting cDNA was PCR amplified for 14 cycles, fragmented, and size selected before Illumina sequencing adaptor and sample indexes were attached. Libraries were sequenced on a NovaSeq 6000 by Novogene UK Ltd (2x150bp paired end reads).

Raw sequencing data were aligned to the unmasked ICSASG_v2 reference assembly (Ensembl release 104) of the Atlantic salmon genome. The analysis used just protein coding genes. Mapping of reads to the genome, assignment of reads to cellular barcodes, and collapsing of unique molecular identifiers (UMIs) was performed using STARsolo v2.7.7a [9]. Settings as described in [8]. The top 100,000 cell barcodes ranked by UMI number were retained to ensure the capture of transcriptionally quiet nuclei, these are normally lost when using the automated STARSolo filtering algorithm. Mapping statistics for each snRNA-Seq sample are provided in Table 7.

Table 7. Sequencing metrics for two biological replicate libraries created with the protocol V1 [7] and two biological replicates for the protocol presented here (V2).

V1a V1b V2a V2b
Number of reads 2.30x108 2.29 x108 2.60 x108 2.29 x108
Uniquely mapped reads 16.5% 22.3% 59.3% 53.5%
Mapping to introns + exons 7.81% 11.2% 50.2% 45.1%
Sequencing saturation 20.0% 25.6% 71.0% 53.2%
Number of UMIs 400,7192 5,577,109 10,055,941 11,059,639
Number of nuclei 4115 6018 2176 2832
Median UMIs/nucleus 767 774 3583 3088
Median genes/nucleus 618 653 2229 2042

Results and discussion

Flash frozen Atlantic salmon skin was used to test both TST extraction protocols. Skin is a challenging tissue on which to perform nuclear isolations. Thus, our rationale was that this protocol will transfer well to a range of tissues with difficult properties, in addition to more straightforward soft tissues.

The raw metrics from the sequencing of the single nucleus libraries are presented in Table 7. The new protocol resulted in a substantial increase in the quality control metrics for both tissues. Compared to the previous protocol, the new one results in the sequencing of a significantly higher fraction of the transcripts contained in the library (“sequencing saturation”)–an increase from 20%-25% to 53%-70%. This translates to capturing more mRNAs in the libraries with the same amount of sequencing. The new version of the protocol sees an increase in both the number of UMIs per nucleus (767–774 to 3088–3583) and in the number of genes per nucleus (618–653 to 2042–2229; Fig 2). This is the result of i) using RNA inhibitor to stop the degradation of RNA during nuclear isolation and library preparation, and ii) changing the loading buffer to PBS+BSA, since the original ST loading buffer has salts that can interfere with the microfluidic chemistry. This increase in data quality will result in improved downstream analyses such as the identification of cell types and performing of differential gene expression tests.

Fig 2. Violin plots visualizing transcript and gene numbers per nucleus in each of the test datasets.

Fig 2

A comparison of transcript and genes numbers obtained using the older version of the TST protocol (V1, red) compared to the protocol in this paper (V2, blue). All libraries are generated from single nucleus suspensions isolated from Atlantic salmon skin samples, an extremely challenged tissue type to perform single nucleus sequencing.

This new protocol has been successfully used to obtain nuclei from a variety of Atlantic salmon (Salmo salar) tissue types, including; liver, spleen, whole blood, leukocytes isolated from the blood, head kidney, gill, fin, as well as skin. It has also been used in our hands to successfully obtain nuclei from various tissues in other species, including the spleen of sheep (Ovis aries), chicken (Gallus gallus) mouse (Mus musculus) and nurse shark (Ginglymostoma cirratum), the olfactory organs of rabbit (Oryctolagus cuniculus) and Senegalese sole (Solea senegalensis), and pig (Sus domesticus) intestine. The protocol has also been used to obtain nuclei from invertebrate species including whiteleg shrimp (Litopenaeus vannamei) hepatopancreas and whole sea lice (Lepeophtheirus salmonis) at the copepod life stage. Based on these test cases, and the results presented here, we are confident the protocol will have wide future applications for snRNA-Seq in a variety of species and tissues.

Supporting information

S1 File

(PDF)

Acknowledgments

Ethics statement

The animal study was reviewed and approved by Centre for Aquaculture technologies and was carried out in compliance guidelines set forth by the Canadian Council for Animal Care, the animal use protocol was approved by the institutional Animal care committee MB-0185.

Data Availability

The raw sequencing files are available from the Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/). Accession number GSE231945; Title: A versatile nuclei extraction protocol for single nucleus sequencing in non-model species - optimization in various Atlantic salmon tissues.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Linnarsson S, Teichmann SA. Single-cell genomics: coming of age. Genome Biol. 2016. May 10;17(1):97. doi: 10.1186/s13059-016-0960-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kulkarni A, Anderson AG, Merullo DP, Konopka G. Beyond bulk: a review of single cell transcriptomics methodologies and applications. Curr Opin Biotechnol. 2019. Aug 1;58:129–36. doi: 10.1016/j.copbio.2019.03.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Slyper M, Porter CBM, Ashenberg O, Waldman J, Drokhlyansky E, Wakiro I, et al. A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nat Med. 2020. May 1;26(5):792–802. doi: 10.1038/s41591-020-0844-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Drokhlyansky E, Smillie CS, Van Wittenberghe N, Ericsson M, Griffin GK, Eraslan G, et al. The Human and Mouse Enteric Nervous System at Single-Cell Resolution. Cell. 2020. Sep 17;182(6):1606–1622.e23. doi: 10.1016/j.cell.2020.08.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Eraslan G, Drokhlyansky E, Anand S, Fiskin E, Subramanian A, Slyper M, et al. Single-nucleus cross-tissue molecular reference maps toward understanding disease gene function. Science. 2022. May 13;376(6594):eabl4290. doi: 10.1126/science.abl4290 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Melms JC, Biermann J, Huang H, Wang Y, Nair A, Tagore S, et al. A molecular single-cell lung atlas of lethal COVID-19. Nature. 2021. Jul;595(7865):114–9. doi: 10.1038/s41586-021-03569-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Daniels Ruiz R, Taylor RS, Robledo D, Macqueen DJ. Single cell genomics as a transformative approach for aquaculture research and innovation. Rev Aquac [Internet]. [cited 2023 Mar 8];. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/raq.12806 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Taylor RS, Ruiz Daniels R, Dobie R, Naseer S, Clark TC, Henderson NC, et al. Single cell transcriptomics of Atlantic salmon (Salmo salar L.) liver reveals cellular heterogeneity and immunological responses to challenge by Aeromonas salmonicida. Front Immunol [Internet]. 2022. [cited 2022 Sep 5];13. Available from: https://www.frontiersin.org/articles/10.3389/fimmu.2022.984799 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kaminow B, Yunusov D, Dobin A. STARsolo: accurate, fast and versatile mapping/quantification of single-cell and single-nucleus RNA-seq dat [Internet]. 2021. [cited 2022 Oct 6]. Available from: 10.1101/2021.05.05.442755 [DOI] [Google Scholar]

Decision Letter 0

Christopher W Reid

28 Feb 2023

PONE-D-22-34938

A versatile nuclei extraction protocol for single nucleus sequencing in non-model species – optimization in various Atlantic salmon tissues

PLOS ONE

Dear Dr. daniels,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 14 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Christopher W Reid, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

3. Please ensure that you include a title page within your main document. You should list all authors and all affiliations as per our author instructions and clearly indicate the corresponding author.

4. Please amend your manuscript to include your abstract after the title page.

5. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

7. We note you have not yet provided a protocols.io PDF version of your protocol and/or a protocols.io DOI. When you submit your revision, please provide a PDF version of your protocol as generated by protocols.io (the file will have the protocols.io logo in the upper right corner of the first page) as a Supporting Information file. The filename should be S1_file.pdf, and you should enter “S1 File” into the Description field. Any additional protocols should be numbered S2, S3, and so on. Please also follow the instructions for Supporting Information captions [https://journals.plos.org/plosone/s/supporting-information#loc-captions]. The title in the caption should read: “Step-by-step protocol, also available on protocols.io.”

Please assign your protocol a protocols.io DOI, if you have not already done so, and include the following line in the Materials and Methods section of your manuscript: “The protocol described in this peer-reviewed article is published on protocols.io (https://dx.doi.org/10.17504/protocols.io.[...]) and is included for printing purposes as S1 File.” You should also supply the DOI in the Protocols.io DOI field of the submission form when you submit your revision.

If you have not yet uploaded your protocol to protocols.io, you are invited to use the platform’s protocol entry service [https://www.protocols.io/we-enter-protocols] for doing so, at no charge. Through this service, the team at protocols.io will enter your protocol for you and format it in a way that takes advantage of the platform’s features. When submitting your protocol to the protocol entry service please include the customer code PLOS2022 in the Note field and indicate that your protocol is associated with a PLOS ONE Lab Protocol Submission. You should also include the title and manuscript number of your PLOS ONE submission.

8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Please pay particular attention to Reviewer #1 comments regarding a comparable assay to the one described. I would agree that the method cited as the comparison is not ideal for comparing to the reported new technique for extracting nuclei from difficult samples. Before proceeding, I would like to see this properly addressed.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript report a protocol which is of utility to the research community and adds value to the published literature?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the protocol been described in sufficient detail?

To answer this question, please click the link to protocols.io in the Materials and Methods section of the manuscript (if a link has been provided) or consult the step-by-step protocol in the Supporting Information files.

The step-by-step protocol should contain sufficient detail for another researcher to be able to reproduce all experiments and analyses.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Does the protocol describe a validated method?

The manuscript must demonstrate that the protocol achieves its intended purpose: either by containing appropriate validation data, or referencing at least one original research article in which the protocol was used to generate data.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. If the manuscript contains new data, have the authors made this data fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Is the article presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please highlight any specific errors that need correcting in the box below.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this manuscript the authors describe a method of nuclei purification that increases yield and quality of the collected sample over previous methods. The authors also present data comparing the end result of their method to the previously used method. Overall, the steps of the manuscript are clear, and the protocol meets its claim as being better suited than the previous method.

Major issues:

Though the data is convincing, I’m not sure that the pervious method of nuclei purification was a truly suitable method for the types of tissues described here, ie. frozen and tough tissue samples. The citation given links to methods used for soft laboratory derived tissues. Considering that I wonder what the justification of using the previous approach would be. Searching the methodologies of projects purifiy nuclei from hard to access tissues, these also use mechanical methods (such as grinding and cutting the tissue). These methodologies however maybe more appropriate as points of comparison.

Reviewer #2: This lab protocol article gives a detailed and easy to follow description of a protocol for extracting nuclei from diverse tissue types and species, for single nucleus sequencing. The article is well written, and I think it provides enough detail for the protocol to be reproduced by other users with varied levels of lab experience. I think this is an excellent protocol to be published in PLOS one. The authors have applied this protocol to a wide range of species and tissue types already which I think demonstrates the potential for the protocol to be used extensively. The quality of single nucleus RNA sequencing data produced from the protocol establish that the protocol could see extensive use for investigating many topics.

I have a few minor comments and suggestions.

TST (4ml) reagent table: Should that be 1,840µl of nuclease-free water to make 4000?

Note at the top of page 10: Can you define nucleus clumping. How would the inexperienced user identify that this is happening?

Workflow step 2: “Keeping the culture place on ice” should that be “placed” on ice?

Workflow step 5: “Gently resuspend the pellet in PBS-BSA using a P1000 pipette” do you mean you remove the supernatant with the pipette and you don’t just pour it off before resuspending?

Results and discussion page 12: “This translates to capturing more mRNAs in the libraries with the same amount of sequencing.” At this point I think it is worth adding more of a discussion about the main reasons why you saw this improvement.

Results and discussion page 13: “The protocol has also also” remove second also

The data from the trail will also have to be uploaded to a public repository.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Ruiz Daniels manuscript_Plos one 2023 review letter.docx

PLoS One. 2023 Sep 7;18(9):e0285020. doi: 10.1371/journal.pone.0285020.r002

Author response to Decision Letter 0


27 Mar 2023

Dear editor and reviewers,

Many thanks for your constructive and helpful comments. These comments have really improved the clarity of the manuscript, and we want to thank the reviewers for their time and effort. We believe their comments have made this protocol more accessible. We have incorporated all the suggestions to the best of our ability. Please find below our point-by-point response. We hope you will find this revised version acceptable for publication. We look forward to hearing your comments.

Sincerely,

Rose Ruiz Daniels

On behalf of all authors

Reviewer 1

In this manuscript the authors describe a method of nuclei purification that increases yield and quality of the collected sample over previous methods. The authors also present data comparing the end result of their method to the previously used method. Overall, the steps of the manuscript are clear, and the protocol meets its claim as being better suited than the previous method.

We thank the reviewer for the positive comments.

Major issues:

Though the data is convincing, I’m not sure that the pervious method of nuclei purification was a truly suitable method for the types of tissues described here, ie. frozen and tough tissue samples. The citation given links to methods used for soft laboratory derived tissues. Considering that I wonder what the justification of using the previous approach would be. Searching the methodologies of projects purifiy nuclei from hard to access tissues, these also use mechanical methods (such as grinding and cutting the tissue). These methodologies however maybe more appropriate as points of comparison.

Thank you, this is a very good point. We have addressed this in the introduction, where we state why ST with chopping is the most appropriate method for this sort of tissue (L111-L115). We have added the appropriate reference to justify the choice of this protocol, and cited previous work that tested these protocols in comparison with other known methods used to purify nuclei, including mechanical methods and gradients. These show that the method we chose for comparison was the best alternative, reducing background contamination while capturing cellular and transcript diversity.

Minor issues:

The second paragraph of the introduction has a lot of “should” “could” “would” “anticipate”. Ideal the paragraph would read more like the first and be more direct and succinct.

Agreed, we have changed the text according to the reviewer suggestions (L120-L130).

Using a glycerol cushion to remove debris instead of a filter.

In order to not clog up the 10X genomics microfluidic device at least a 40 um filter is required – this is the manufacturers recommendation for the device. While a glycerol cushion may work, the protocol must be carried out at 4C, which would impact the viscosity of the glycerol and increase the protocol time - both of which may have negative consequences on nuclei viability.

Not sure why the whole protocol is rehashed in the “testing the protocol” section. In this section it seems that it would be most appropriate to explain what experiment was set up or just scrap it and have a results section.

We have improved this section by removing the repetition and instead describing the optimizations in the new protocol (L299-L311)

Citations were done improperly, please check the Plos One guidelines.

Thank you for pointing this out. We have corrected the references.

It is hard to determine what the actual changes in the protocol are actually doing and whether or not this group is just much better than others at collecting nuclei. Part of this I believe is the structure of the article.

We have clarified the justifications for the modifications in L291-297. We have tested both versions of the protocol in-house, with and without the changes and the purpose of this section and results is to show the changes improved the protocol substantially. In particular, the extraction of nuclei out of very challenging tissues such as skin is improved. We present results that shows that these changes have had an effect on library quality.

Line 21 – typo, word missing

Corrected, thank you.

Line 131 – clarify what is adjusted. This statement about the time isn’t very clear. It might be clearer to state that dissociation takes up to 10 minutes. “First 5 minutes of mincing and then pipetting for up to 5 minutes checking every minute for completion of nuclei dissociation.”

We have tried to clarify this (L236-L243) and the passage now reads: “The total time in the dissociation buffer is critical and the duration of the scissor and pipette steps needs optimisation using non-valuable samples. The use of scissors should be the minimum time necessary for no solid lumps of tissue to remain. Pipetting duration is optimised by observing the nuclei under a microscope and adjusting the dissociation time to the minimum needed for full dissociation and lysing of cells (Figure 1). Typical tissue dissociation takes a total of 5-10 minutes. Non-tissue samples such as blood samples require as little as 1 minute of gentle pipetting in the TST and no use of scissors.”

Line 132 – two sentences

Corrected.

Line 140 – to be more universal, should the centrifuge time just be set to 10 minutes.

Good point. The reason we do not feel 10 minutes is always appropriate is that longer duration (and higher speeds) can result in significant clumping of nuclei in samples which large recovery rates. We have clarified this point in the text – it should useful to readers as this is an issue we have encountered in the past: “When nuclei yield is low, centrifugation time can be increased to 10 minutes to maximise yield. In samples with high recovery 10 minutes is not recommended as longer centrifugation duration can result in the clumping of nuclei and higher doublet rates in the final data.”

Line 163 – seems that this should be stated in the discussion or at the least a sub step of step 7. This also seems to be a specific type of equipment that isn’t available to everyone, where as a haemocytometer is more readily available.

Any haemocytometer that can be used for counting nuclei is suitable and text adjusted accordingly.

Line 180 – should be reworded to not “hang” on the citation or state “from Drokhlyansky and colleagues4”. There are several places in the manuscript this is done and there are ways around it.

We have adjusted this in the text to improve readability.

Line 180-206 – It sounds like you tested your version to the previous published version. I believe that you should just state that and reference the changes you made. I’m not sure why the whole protocol is restated.

Agreed, we have modified this section which now only states the changes (L291-297)

Figure 2 - Not sure why figure two isn’t just a bar graph. Using these shapes indicates that there is other information here. If that is the case, it should be explain, otherwise standard bar graphs should be used.

The violin plots describe the distribution of transcripts and genes per nucleus across the whole dataset, which in heterogeneous tissue samples such as skin can be highly variable across cell types. For this reason, violin plots are commonly used in single cell studies e.g. a tissue sample with only two cell types with very different transcriptional activity would show a bimodal distribution in a violin plot, which is missed in a standard bar graph. We have changed the figure text to explain this:

Figure 2 – typo in the legend

We have made edits to the legend: “Violin plots visualizing transcript and gene numbers per nucleus in each of the test datasets. A comparison of transcript and genes numbers obtained using the older version of the TST protocol (V1, red) compared to the protocol in this paper (V2, blue). All libraries are generated from single nucleus suspensions isolated from Atlantic salmon skin samples, an extremely challenged tissue type to perform single nucleus sequencing.”

Reviewer #2: This lab protocol article gives a detailed and easy to follow description of a protocol for extracting nuclei from diverse tissue types and species, for single nucleus sequencing. The article is well written, and I think it provides enough detail for the protocol to be reproduced by other users with varied levels of lab experience. I think this is an excellent protocol to be published in PLOS one. The authors have applied this protocol to a wide range of species and tissue types already which I think demonstrates the potential for the protocol to be used extensively. The quality of single nucleus RNA sequencing data produced from the protocol establish that the protocol could see extensive use for investigating many topics.

We thank the reviewer for their positive comments, we are really glad that they think this protocol could be widely useful to other researchers. We certainly hope so.

I have a few minor comments and suggestions.

TST (4ml) reagent table: Should that be 1,840µl of nuclease-free water to make 4000?

Correct! We have amended this.

Note at the top of page 10: Can you define nucleus clumping. How would the inexperienced user identify that this is happening?

We have amended this text, which now reads:

“It is possible that nuclei may stick together in clumps after centrifugation. This can be observed under a microscope (figure 1A illustrates an example of this). This is undesirable as it may lead to high rates of “doublets” (more than one nucleus being encapsulated in a single droplet in the microfluidics system, resulting in each transcript being labelled with the same cellular barcode).”

Workflow step 2: “Keeping the culture place on ice” should that be “placed” on ice?

Correct, “place” was a typo that now reads “plate”.

Workflow step 5: “Gently resuspend the pellet in PBS-BSA using a P1000 pipette” do you mean you remove the supernatant with the pipette and you don’t just pour it off before resuspending?

We have clarified the text to mentioned removing the supernatant prior to resuspension.

Results and discussion page 12: “This translates to capturing more mRNAs in the libraries with the same amount of sequencing.” At this point I think it is worth adding more of a discussion about the main reasons why you saw this improvement.

The improved results are the combined effect of the use of RNAse inhibitor and the change in loading buffer. The impact of RNAse inhibitor is relatively straightforward, since it stops the degradation of RNA during the nuclear isolation and library preparation stages. Regarding loading buffer, the previous one (ST) had salts that can interfere with the microfluidic chemistry. We have added this information as suggested (L350-353).

Results and discussion page 13: “The protocol has also also” remove second also

Corrected, thank you.

The data from the trail will also have to be uploaded to a public repository.

We have now uploaded the data to a public repository. We have yet to obtain an accession from NCBI but this will be added prior to publication. We have added a data availability statement (L368-L371) with a placeholder for the accession number.

Attachment

Submitted filename: Response to Reviewers_Ruiz Daniels _24_03_2023.docx

Decision Letter 1

Sven Winter

13 Apr 2023

A versatile nuclei extraction protocol for single nucleus sequencing in non-model species – optimization in various Atlantic salmon tissues

PONE-D-22-34938R1

Dear Dr. Ruiz Daniels,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Sven Winter

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript report a protocol which is of utility to the research community and adds value to the published literature?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the protocol been described in sufficient detail?

To answer this question, please click the link to protocols.io in the Materials and Methods section of the manuscript (if a link has been provided) or consult the step-by-step protocol in the Supporting Information files.

The step-by-step protocol should contain sufficient detail for another researcher to be able to reproduce all experiments and analyses.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Does the protocol describe a validated method?

The manuscript must demonstrate that the protocol achieves its intended purpose: either by containing appropriate validation data, or referencing at least one original research article in which the protocol was used to generate data.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. If the manuscript contains new data, have the authors made this data fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the article presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please highlight any specific errors that need correcting in the box below.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: To the Editor,

I believe that the changes made by the authors of the Ruiz Daniels manuscript are sufficient and would support the decision of the editor to accept this paper.

Sincerely,

Steven Weicksel

Reviewer #2: This is the second time I have reviewed this manuscript and I think the reviewers have done an excellent job of responding to all reviewer comments. I also think this clearly described protocol could be useful to many projects in the future.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Samuel C. Andrew

**********

Attachment

Submitted filename: Ruiz Daniels manuscript_Plos one 2023 review letter_R1.pdf

Acceptance letter

Sven Winter

11 May 2023

PONE-D-22-34938R1

A versatile nuclei extraction protocol for single nucleus sequencing in non-model species – optimization in various Atlantic salmon tissues

Dear Dr. Ruiz Daniels:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Sven Winter

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (PDF)

    Attachment

    Submitted filename: Ruiz Daniels manuscript_Plos one 2023 review letter.docx

    Attachment

    Submitted filename: Response to Reviewers_Ruiz Daniels _24_03_2023.docx

    Attachment

    Submitted filename: Ruiz Daniels manuscript_Plos one 2023 review letter_R1.pdf

    Data Availability Statement

    The raw sequencing files are available from the Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/). Accession number GSE231945; Title: A versatile nuclei extraction protocol for single nucleus sequencing in non-model species - optimization in various Atlantic salmon tissues.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES